Organic & Biomolecular Chemistry · 2011 · 24 citations · 56 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryEnzymologyChagas DiseaseEnzyme InhibitionProtozoan PathogenesisAntimicrobial Growth InhibitionEnzymesFatty AcidsToxoplasmosis PathogenesisTreatment Of TrypanosomiasisTrypanosoma Cruzi InfectionTrypanosoma Cruzi Life Cycle
α-Fluorinated-1,1-bisphosphonic acids derived from fatty acids were designed, synthesized and biologically evaluated against Trypanosoma cruzi, the etiologic agent of Chagas disease, and against Toxoplasma gondii, the agent responsible for toxoplasmosis, and also towards the target parasitic enzymes farnesyl pyrophosphate synthase of T. cruzi (TcFPPS) and T. gondii (TgFPPS). Interestingly, 1-fluorononylidene-1,1-bisphosphonic acid (compound 43) proved to be an extremely potent inhibitor of the enzymatic activity of TgFPPS at the low nanomolar range, exhibiting an IC(50) of 30 nM. This compound was two-fold more potent than risedronate (IC(50) = 74 nM) that was taken as a positive control. This enzymatic activity was associated with a strong cell growth inhibition against tachyzoites of T. gondii, with an IC(50) value of 2.7 μM.
56
Multiple sequence alignment with Clustal X
François Jeanmougin, Julie Thompson, Manolo Gouy et al. · Trends in Biochemical Sciences · 1998 · 2.7K citations
James E. Dunford, Keith Thompson, Fraser P. Coxon et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 896 citations
A Newly Revised Classification of the Protozoa*
Norman D. Levine, John O. Corliss, F. E. G. Cox et al. · The Journal of Protozoology · 1980 · 834 citations · Full text